Results 211 to 220 of about 57,167 (281)

Beyond BMI: Practical Guide for Clinicians to Integrate the Lancet Commission's Obesity Framework and King's Obesity Staging System

open access: yesClinical Obesity, EarlyView.
ABSTRACT Body mass index (BMI) on its own is a poor diagnostic and staging tool for obesity because it does not measure health status. The newly published Lancet Clinical Obesity Criteria (LCOC) for defining clinical obesity distinguish preclinical and clinical obesity based on organ or tissue dysfunction.
Tak Ying Louise Ko   +3 more
wiley   +1 more source

Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis

open access: bronze, 2001
Süleyman Türk   +6 more
openalex   +1 more source

Looking for the Best Way to Come Off Steroids Safely? Exploring Post‐Cycle Therapy, Cessation, and Recovery Discourse and Practice in Australian Steroid Consumer Forums

open access: yesDrug and Alcohol Review, EarlyView.
ABSTRACT Introduction Anabolic‐androgenic steroid (AAS) use is rising in Australia; however, discontinuation poses challenges due to withdrawal symptoms and a lack of clinical guidance. Therefore, the aim of this study was to explore online discourses around post‐cycle therapy (PCT), including perceived health risks, benefits and barriers, among people
Jonathan Easton   +4 more
wiley   +1 more source

Central nervous system involvement in cardiac amyloidosis: Redefining the heart‐brain axis

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Central nervous system involvement in cardiac amyloidosis. Amyloidosis is a systemic disease that can directly affect the central nervous system. Furthermore, the amyloid cardiomyopathy can indirectly affect the central nervous system by inducing systemic hypoperfusion and increasing the risk of acute ischaemic stroke.
Domenico Mario Giamundo   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy